These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 10820247)
1. IL-4 promotes the migration of circulating B cells to the spleen and increases splenic B cell survival. Mori M; Morris SC; Orekhova T; Marinaro M; Giannini E; Finkelman FD J Immunol; 2000 Jun; 164(11):5704-12. PubMed ID: 10820247 [TBL] [Abstract][Full Text] [Related]
2. IL-4 promotes Stat6-dependent survival of autoreactive B cells in vivo without inducing autoantibody production. Morris SC; Dragula NL; Finkelman FD J Immunol; 2002 Aug; 169(4):1696-704. PubMed ID: 12165489 [TBL] [Abstract][Full Text] [Related]
3. In vivo survival of autoreactive B cells: characterization of long-lived B cells. Morris SC; Moroldo M; Giannini EH; Orekhova T; Finkelman FD J Immunol; 2000 Mar; 164(6):3035-46. PubMed ID: 10706692 [TBL] [Abstract][Full Text] [Related]
4. Single cell analysis reveals that IL-4 receptor/Stat6 signaling is not required for the in vivo or in vitro development of CD4+ lymphocytes with a Th2 cytokine profile. Jankovic D; Kullberg MC; Noben-Trauth N; Caspar P; Paul WE; Sher A J Immunol; 2000 Mar; 164(6):3047-55. PubMed ID: 10706693 [TBL] [Abstract][Full Text] [Related]
5. Cutting edge: STAT6 serves as a positive and negative regulator of gene expression in IL-4-stimulated B lymphocytes. Schroder AJ; Pavlidis P; Arimura A; Capece D; Rothman PB J Immunol; 2002 Feb; 168(3):996-1000. PubMed ID: 11801631 [TBL] [Abstract][Full Text] [Related]
7. A role for c-fos/activator protein 1 in B lymphocyte terminal differentiation. Ohkubo Y; Arima M; Arguni E; Okada S; Yamashita K; Asari S; Obata S; Sakamoto A; Hatano M; O-Wang J; Ebara M; Saisho H; Tokuhisa T J Immunol; 2005 Jun; 174(12):7703-10. PubMed ID: 15944271 [TBL] [Abstract][Full Text] [Related]
8. Reduction of early B lymphocyte precursors in transgenic mice overexpressing the murine heat-stable antigen. Hough MR; Chappel MS; Sauvageau G; Takei F; Kay R; Humphries RK J Immunol; 1996 Jan; 156(2):479-88. PubMed ID: 8543797 [TBL] [Abstract][Full Text] [Related]
9. Resistance to metastatic disease in STAT6-deficient mice requires hemopoietic and nonhemopoietic cells and is IFN-gamma dependent. Ostrand-Rosenberg S; Clements VK; Terabe M; Park JM; Berzofsky JA; Dissanayake SK J Immunol; 2002 Nov; 169(10):5796-804. PubMed ID: 12421960 [TBL] [Abstract][Full Text] [Related]
10. Signaling through TNF receptor p55 in TNF-alpha-deficient mice alters the CXCL13/CCL19/CCL21 ratio in the spleen and induces maturation and migration of anergic B cells into the B cell follicle. Mandik-Nayak L; Huang G; Sheehan KC; Erikson J; Chaplin DD J Immunol; 2001 Aug; 167(4):1920-8. PubMed ID: 11489971 [TBL] [Abstract][Full Text] [Related]
11. Stat6 regulation of in vivo IL-4 responses. Finkelman FD; Morris SC; Orekhova T; Mori M; Donaldson D; Reiner SL; Reilly NL; Schopf L; Urban JF J Immunol; 2000 Mar; 164(5):2303-10. PubMed ID: 10679064 [TBL] [Abstract][Full Text] [Related]
12. IL-7 up-regulates IL-4 production by splenic NK1.1+ and NK1.1- MHC class I-like/CD1-dependent CD4+ T cells. Hameg A; Gouarin C; Gombert JM; Hong S; Van Kaer L; Bach JF; Herbelin A J Immunol; 1999 Jun; 162(12):7067-74. PubMed ID: 10358149 [TBL] [Abstract][Full Text] [Related]
13. Immune-mediated neuroprotection of axotomized mouse facial motoneurons is dependent on the IL-4/STAT6 signaling pathway in CD4(+) T cells. Deboy CA; Xin J; Byram SC; Serpe CJ; Sanders VM; Jones KJ Exp Neurol; 2006 Sep; 201(1):212-24. PubMed ID: 16806176 [TBL] [Abstract][Full Text] [Related]
14. Stat6 is necessary and sufficient for IL-4's role in Th2 differentiation and cell expansion. Zhu J; Guo L; Watson CJ; Hu-Li J; Paul WE J Immunol; 2001 Jun; 166(12):7276-81. PubMed ID: 11390477 [TBL] [Abstract][Full Text] [Related]
15. A novel Rac-dependent checkpoint in B cell development controls entry into the splenic white pulp and cell survival. Henderson RB; Grys K; Vehlow A; de Bettignies C; Zachacz A; Henley T; Turner M; Batista F; Tybulewicz VL J Exp Med; 2010 Apr; 207(4):837-53. PubMed ID: 20308364 [TBL] [Abstract][Full Text] [Related]
16. Enhanced differentiation of splenic plasma cells but diminished long-lived high-affinity bone marrow plasma cells in aged mice. Han S; Yang K; Ozen Z; Peng W; Marinova E; Kelsoe G; Zheng B J Immunol; 2003 Feb; 170(3):1267-73. PubMed ID: 12538685 [TBL] [Abstract][Full Text] [Related]
17. TNF-TNFR2 interactions are critical for the development of intestinal graft-versus-host disease in MHC class II-disparate (C57BL/6J-->C57BL/6J x bm12)F1 mice. Brown GR; Lee E; Thiele DL J Immunol; 2002 Mar; 168(6):3065-71. PubMed ID: 11884480 [TBL] [Abstract][Full Text] [Related]
18. Decreased E12 and/or E47 transcription factor activity in the bone marrow as well as in the spleen of aged mice. Frasca D; Nguyen D; Riley RL; Blomberg BB J Immunol; 2003 Jan; 170(2):719-26. PubMed ID: 12517933 [TBL] [Abstract][Full Text] [Related]
19. Administration of IL-7 to normal mice stimulates B-lymphopoiesis and peripheral lymphadenopathy. Morrissey PJ; Conlon P; Charrier K; Braddy S; Alpert A; Williams D; Namen AE; Mochizuki D J Immunol; 1991 Jul; 147(2):561-8. PubMed ID: 1712810 [TBL] [Abstract][Full Text] [Related]
20. Anti-cytokine antibodies as carrier proteins. Prolongation of in vivo effects of exogenous cytokines by injection of cytokine-anti-cytokine antibody complexes. Finkelman FD; Madden KB; Morris SC; Holmes JM; Boiani N; Katona IM; Maliszewski CR J Immunol; 1993 Aug; 151(3):1235-44. PubMed ID: 8393043 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]